Related Experiment Video

Updated: Jun 30, 2026

Generation of Human CD40-activated B cells
13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

14.9K

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem

Jenny Yeung, Aiyin Liao, Matthew Shaw

    Molecular Therapy : the Journal of the American Society of Gene Therapy
    |April 28, 2026
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
    09:29

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

    Published on: February 1, 2013

    19.7K
    Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
    11:02

    Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

    Published on: September 14, 2018

    8.6K

    Related Experiment Videos

    Last Updated: Jun 30, 2026

    Generation of Human CD40-activated B cells
    13:27

    Generation of Human CD40-activated B cells

    Published on: October 16, 2009

    14.9K
    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
    09:29

    Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

    Published on: February 1, 2013

    19.7K
    Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
    11:02

    Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

    Published on: September 14, 2018

    8.6K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Life-threatening hepatic complications in children with ADA-SCID.

    Journal of human immunity·2026

    Clinical and biochemical correction of a patient with neurodegenerative Mucopolysaccharidosis IIIA using hematopoietic stem cell gene therapy.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    In-depth characterization of stem cell potency and genotoxicity for clinical-scale ex vivo CRISPR-Cas9 gene editing.

    Molecular therapy. Advances·2026

    A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Functional restoration of immune defects in STAT1 gain-of-function disease following stem cell gene editing.

    Blood·2026

    Gene therapy approaches for inborn errors of immunity: from bench to bedside.

    Expert opinion on biological therapy·2026

    miR-124 delivery to the hippocampus reduces excitability, enhances neurogenesis and affects microglia in a model of Alzheimer's disease.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Intramuscular Non-replicating Tiantan Vaccinia Drives Superior Antibody Maturation and Sterilizing Protection Against Lethal Orthopoxvirus Challenge in Mice.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Five decades of gene therapy innovation and regulation in the US and EU: a historical analysis.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Sustained Relief of Chronic Pain via a Nav1.7-Targeting ASO-siRNA Conjugate in Rats.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Dendrimer Delivered shRNA Targeting the CCL20-CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain Injury.

    Molecular therapy : the journal of the American Society of Gene Therapy·2026

    Case report of sequential, bilateral, robotic-assisted lung resections for severe bronchiectasis.

    AME case reports·2026

    A hypoxia-responsive calixarene supramolecular system enables redox-regulated matrix remodeling for postmenopausal osteoporosis.

    Materials today. Bio·2026

    Calcimimetic therapy modified the radiological, surgical, and histopathological features of a parathyroid adenoma.

    JCEM case reports·2026

    FLOT versus SOX as immunochemotherapy backbones for neoadjuvant or conversion therapy in gastric cancer: efficacy, toxicity, and postoperative safety in a real-world cohort.

    Frontiers in immunology·2026

    Correction: The intratumoral microbiome in colorectal cancer: origins, microenvironmental interactions, and new horizons in precision medicine.

    Frontiers in immunology·2026

    Reconstruction of the inferior vena cava using the right ovarian vein following resection of renal cell carcinoma with tumor thrombus directly infiltrating the inferior vena cava: a case report.

    AME case reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us